Literature DB >> 29029192

Paracoccidioidomycosis Associated With a Heterozygous STAT4 Mutation and Impaired IFN-γ Immunity.

Lena F Schimke1,2, James Hibbard3, Ruben Martinez-Barricarte4, Taj Ali Khan1, Ricardo de Souza Cavalcante5, Edgar Borges de Oliveira Junior1, Tabata Takahashi França1, Asif Iqbal6, Guilherme Yamamoto7, Christina Arslanian1, Claudia Feriotti1, Tania Alves Costa1, Jacinta Bustamante4,8,9,10, Stéphanie Boisson-Dupuis4,8,9, Jean-Laurent Casanova4,8,9,11,12, José Alexandre Marzagao Barbuto1, Mayana Zatz7, Rinaldo Poncio Mendes5, Vera Lucia Garcia Calich1, Hans D Ochs3, Troy R Torgerson3, Otávio Cabral-Marques1,2, Antonio Condino-Neto1,13.   

Abstract

Background: Mutations in genes affecting interferon-γ (IFN-γ) immunity have contributed to understand the role of IFN-γ in protection against intracellular pathogens. However, inborn errors in STAT4, which controls interleukin-12 (IL-12) responses, have not yet been reported. Our objective was to determine the genetic defect in a family with a history of paracoccidioidomycosis.
Methods: Genetic analysis was performed by whole-exome sequencing and Sanger sequencing. STAT4 phosphorylation (pSTAT4) and translocation to the nucleus, IFN-γ release by patient lymphocytes, and microbicidal activity of patient monocytes/macrophages were assessed. The effect on STAT4 function was evaluated by site-directed mutagenesis using a lymphoblastoid B cell line (B-LCL) and U3A cells.
Results: A heterozygous missense mutation, c.1952 A>T (p.E651V) in STAT4 was identified in the index patient and her father. Patient's and father's lymphocytes showed reduced pSTAT4, nuclear translocation, and impaired IFN-γ production. Mutant B-LCL and U3A cells also displayed reduced pSTAT4. Patient's and father's peripheral blood mononuclear cells and macrophages demonstrated impaired fungicidal activity compared with those from healthy controls that improved in the presence of recombinant human IFN-γ, but not rhIL-12.
Conclusion: Our data suggest autosomal dominant STAT4 deficiency as a novel inborn error of IL-12-dependent IFN-γ immunity associated with susceptibility to paracoccidioidomycosis.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  IL-12/IFN-γ axis; STAT4 deficiency; paracoccidioidomycosis; primary immunodeficiency

Mesh:

Substances:

Year:  2017        PMID: 29029192     DOI: 10.1093/infdis/jix522

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Mouse Model of a Human STAT4 Point Mutation That Predisposes to Disseminated Coccidiomycosis.

Authors:  Daniel A Powell; Amy P Hsu; Lisa F Shubitz; Christine D Butkiewicz; Hilary Moale; Hien T Trinh; Thomas Doetschman; Teodora G Georgieva; Dakota M Reinartz; Justin E Wilson; Marc J Orbach; Steven M Holland; John N Galgiani; Jeffrey A Frelinger
Journal:  Immunohorizons       Date:  2022-02-11

Review 2.  JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition.

Authors:  Yiming Luo; Madison Alexander; Massimo Gadina; John J O'Shea; Francoise Meylan; Daniella M Schwartz
Journal:  J Allergy Clin Immunol       Date:  2021-10       Impact factor: 14.290

3.  Novel nonsense IL-12Rβ1 mutation associated with recurrent tuberculosis.

Authors:  Noor Ul Akbar; Shahid Niaz Khan; Muhammad Usman Amin; Muhammad Ishfaq; Otavio Cabral-Marques; Lena F Schimke; Asif Iqbal; Ikram Ullah; Mubashir Hussain; Ijaz Ali; Nasar Khan; Nadia El Khawanky; Hazir Rahman; Taj Ali Khan
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

4.  β2 Integrin-Mediated Susceptibility to Paracoccidioides brasiliensis Experimental Infection in Mice.

Authors:  Stephan Alberto Machado de Oliveira; Janayna Nunes Reis; Elisa Catão; Andre Correa Amaral; Ana Camila Oliveira Souza; Alice Melo Ribeiro; Lúcia Helena Faccioli; Fabiana Pirani Carneiro; Clara Luna Freitas Marina; Pedro Henrique Bürgel; Larissa Fernandes; Aldo Henrique Tavares; Anamelia Lorenzetti Bocca
Journal:  Front Cell Infect Microbiol       Date:  2021-03-16       Impact factor: 5.293

5.  The network interplay of interferon and Toll-like receptor signaling pathways in the anti-Candida immune response.

Authors:  Ranieri Coelho Salgado; Dennyson Leandro M Fonseca; Alexandre H C Marques; Sarah Maria da Silva Napoleao; Tábata Takahashi França; Karen Tiemi Akashi; Caroline Aliane de Souza Prado; Gabriela Crispim Baiocchi; Desirée Rodrigues Plaça; Gabriel Jansen-Marques; Igor Salerno Filgueiras; Roberta De Vito; Paula Paccielli Freire; Gustavo Cabral de Miranda; Niels Olsen Saraiva Camara; Vera Lúcia Garcia Calich; Hans D Ochs; Lena F Schimke; Igor Jurisica; Antonio Condino-Neto; Otavio Cabral-Marques
Journal:  Sci Rep       Date:  2021-10-13       Impact factor: 4.379

Review 6.  Human growth disorders associated with impaired GH action: Defects in STAT5B and JAK2.

Authors:  Vivian Hwa
Journal:  Mol Cell Endocrinol       Date:  2020-10-27       Impact factor: 4.102

Review 7.  Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors-A Strategy for Hematological Malignancies?

Authors:  Klara Klein; Dagmar Stoiber; Veronika Sexl; Agnieszka Witalisz-Siepracka
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

Review 8.  Genetic susceptibility to fungal infection in children.

Authors:  Sebastian Ochoa; Gregory M Constantine; Michail S Lionakis
Journal:  Curr Opin Pediatr       Date:  2020-12       Impact factor: 2.893

Review 9.  JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation.

Authors:  Dagmar Gotthardt; Jana Trifinopoulos; Veronika Sexl; Eva Maria Putz
Journal:  Front Immunol       Date:  2019-11-12       Impact factor: 7.561

Review 10.  Genetic causes of growth hormone insensitivity beyond GHR.

Authors:  Vivian Hwa; Masanobu Fujimoto; Gaohui Zhu; Wen Gao; Corinne Foley; Meenasri Kumbaji; Ron G Rosenfeld
Journal:  Rev Endocr Metab Disord       Date:  2020-10-08       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.